1-Ethyl-4-((4-(trans-4-propylcyclohexyl)phenyl)ethynyl)benzene, 97%, 25g

2,2'-Cyclopropylidenebis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane)>98.0%(GC)100mg

4-(Difluoromethoxy)picolinic acid, 250mg

4'-Fluorobiphenyl-2-ylamine hydrochloride, 250mg

5-Hydroxy-3-methylpicolinonitrile, 95.0%, 100mg

2,4-Diethyl-9H-thioxanthen-9-one, 95.0%, 25g

Methyl 2-bromo-4-fluoro-5-nitrobenzoate, 98.0%, 10g

2-Ethylhexanoic acid 250mL, >=99%, for synthesis, 250mL, glass packaging

4-(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)benzene-1,3-diol, 95.0%, 50g

N-(2-((4-Chlorobenzyl)thio)benzo[d]thiazol-6-yl)-2-(morpholine-4-carbonyl)benzamide, 97%, 50mg

tert-Butyl 4-(3-aminophenyl)piperazine-1-carboxylate, 95.0%, 5g

(R)-4-Hydroxy-2-pyrrolidinone, 95.0%, 1g

2,3,5,6-Tetrafluoro-4-methoxybenzenesulfonylchloride, 95%, 1g